Wednesday, November 19, 2008: 8:30 AM
Room 106-B (Pennsylvania Convention Center)
Glycosylated Biopharmaceutcals are usually produced by suspended mammalian cells (typically Chinese Hamster Ovarium (CHO) cells) cultured in stirred tank bioreactors. However, screening protocols at the lab scale (i.e. to find optimum culture media or initial cell density) mainly rely on Petri dish, bottle or Erlenmeyer flask culture. There is an evident need for small scale fully scalable mammalian cell culture mini-bioreactors for screening processes. Here, we study the mixing performance, mass transfer capabilities, and culture adequacy of 30 mL eccentric stirred tanks. A detailed mixing characterization of the proposed bioreactor is presented. LIF experiments and CFD computations are used to identify operational conditions required for adequate mixing (globally chaotic conditions). Suspended CHO cells are cultured in this novel bioreactor system, and results are compared versus Erlenmeyer flask cultivation. Our results demonstrate good mixing performance, culture convenience, and potential scalability of the proposed screening bioreactor.
See more of this Session: New Approaches In Upstream Bioprocessing: Development and Manufacturing
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
![[ Visit Client Website ]](images/banner.gif)